Arête Therapeutics Inc. founded in December 2003 develops and commercializes new small molecule drugs directed at novel targets for cardiovascular diseases and inflammation. The Company's proprietary therapies are directed at a new branch of arachidonic acid metabolism, a proven (US $10B+) pathway for therapeutic intervention in a variety of inflammatory diseases.